Monthly Archives: April 2012

Long: Ajanta Pharma update

Posted on April 21, 2012 by investingkitten

20120421 A promoter group company GABS investments has been buying aggressively from open market. The stock has touched 550. The board is to consider subdivision of equity shares and dividend on 26th April. I contacted investor relations. I could not … Continue reading →

Posted in Long | Tagged , , , , , | Leave a comment

Avoid: Renaissance Jewellery

Posted on April 14, 2012 by investingkitten

20120414 It’s a M-cap 150cr SEEPZ Mumbai based jewellery house available at an attractive PE of 3.8. I didn’t find anything interesting or controversial on it’s website, news items and annual report, other than the following facts Cons: The company … Continue reading →

Posted in Avoid (neutral, stay away) | Tagged , , , , , | Leave a comment

Avoid: Lanco Infra

Posted on April 8, 2012 by investingkitten

20120408 Hyderabad based Lanco (BSE200) doesn’t need much introduction. It has installed capacity of 3GW in 7 thermal, 4 major hydro and rest in wind and solar. Cons: It’s mostly a power company. 80% of its power off-take is tied … Continue reading →

Posted in Avoid (neutral, stay away) | Tagged , , , , , , , | 2 Comments

Avoid: Alembic & Alembic Pharma

Posted on April 6, 2012 by investingkitten

20120406 If I were to ask a common person what’s common between glycodin and yera glass-ware, I may get a blank face. I will get as much of a blank face if I were to ask who was the commissioner … Continue reading →

Posted in Avoid (neutral, stay away) | Tagged , , , , | 1 Comment

Long: Cairn India (update)

Posted on April 4, 2012 by investingkitten

20120404 Cairn India was up 4.66% today on news of second oil discovery in KG basin. It has 49% ownership in the block while the remaining 51% is held by state-owned ONGC.

Posted in Long | Tagged , , , , , | Leave a comment